An Optogenetic‐Controlled Cell Reprogramming System for Driving Cell Fate and Light‐Responsive Chimeric Mice

Abstract Pluripotent stem cells (PSCs) hold great promise for cell‐based therapies, disease modeling, and drug discovery. Classic somatic cell reprogramming to generate induced pluripotent stem cells (iPSCs) is often achieved based on overexpression of transcription factors (TFs). However, this proc...

Full description

Bibliographic Details
Main Authors: Meiyan Wang, Yuanxiao Liu, Ziwei Wang, Longliang Qiao, Xiaoding Ma, Lingfeng Hu, Deqiang Kong, Yuan Wang, Haifeng Ye
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.202202858
_version_ 1797688117366358016
author Meiyan Wang
Yuanxiao Liu
Ziwei Wang
Longliang Qiao
Xiaoding Ma
Lingfeng Hu
Deqiang Kong
Yuan Wang
Haifeng Ye
author_facet Meiyan Wang
Yuanxiao Liu
Ziwei Wang
Longliang Qiao
Xiaoding Ma
Lingfeng Hu
Deqiang Kong
Yuan Wang
Haifeng Ye
author_sort Meiyan Wang
collection DOAJ
description Abstract Pluripotent stem cells (PSCs) hold great promise for cell‐based therapies, disease modeling, and drug discovery. Classic somatic cell reprogramming to generate induced pluripotent stem cells (iPSCs) is often achieved based on overexpression of transcription factors (TFs). However, this process is limited by side effect of overexpressed TFs and unpredicted targeting of TFs. Pinpoint control over endogenous TFs expression can provide the ability to reprogram cell fate and tissue function. Here, a light‐inducible cell reprogramming (LIRE) system is developed based on a photoreceptor protein cryptochrome system and clustered regularly interspaced short palindromic repeats/nuclease‐deficient CRISPR‐associated protein 9 for induced PSCs reprogramming. This system enables remote, non‐invasive optogenetical regulation of endogenous Sox2 and Oct4 loci to reprogram mouse embryonic fibroblasts into iPSCs (iPSCLIRE) under light‐emitting diode‐based illumination. iPSCLIRE cells can be efficiently differentiated into different cells by upregulating a corresponding TF. iPSCLIRE cells are used for blastocyst injection and optogenetic chimeric mice are successfully generated, which enables non‐invasive control of user‐defined endogenous genes in vivo, providing a valuable tool for facile and traceless controlled gene expression studies and genetic screens in mice. This LIRE system offers a remote, traceless, and non‐invasive approach for cellular reprogramming and modeling of complex human diseases in basic biological research and regenerative medicine applications.
first_indexed 2024-03-12T01:27:25Z
format Article
id doaj.art-9546ebbefec046f1b6d995d193e62074
institution Directory Open Access Journal
issn 2198-3844
language English
last_indexed 2024-03-12T01:27:25Z
publishDate 2023-02-01
publisher Wiley
record_format Article
series Advanced Science
spelling doaj.art-9546ebbefec046f1b6d995d193e620742023-09-12T14:40:47ZengWileyAdvanced Science2198-38442023-02-01104n/an/a10.1002/advs.202202858An Optogenetic‐Controlled Cell Reprogramming System for Driving Cell Fate and Light‐Responsive Chimeric MiceMeiyan Wang0Yuanxiao Liu1Ziwei Wang2Longliang Qiao3Xiaoding Ma4Lingfeng Hu5Deqiang Kong6Yuan Wang7Haifeng Ye8Shanghai Frontiers Science Center of Genome Editing and Cell Therapy Biomedical Synthetic Biology Research Center Shanghai Key Laboratory of Regulatory Biology Institute of Biomedical Sciences and School of Life Sciences East China Normal University Dongchuan Road 500 Shanghai 200241 ChinaShanghai Frontiers Science Center of Genome Editing and Cell Therapy Biomedical Synthetic Biology Research Center Shanghai Key Laboratory of Regulatory Biology Institute of Biomedical Sciences and School of Life Sciences East China Normal University Dongchuan Road 500 Shanghai 200241 ChinaShanghai Frontiers Science Center of Genome Editing and Cell Therapy Biomedical Synthetic Biology Research Center Shanghai Key Laboratory of Regulatory Biology Institute of Biomedical Sciences and School of Life Sciences East China Normal University Dongchuan Road 500 Shanghai 200241 ChinaShanghai Frontiers Science Center of Genome Editing and Cell Therapy Biomedical Synthetic Biology Research Center Shanghai Key Laboratory of Regulatory Biology Institute of Biomedical Sciences and School of Life Sciences East China Normal University Dongchuan Road 500 Shanghai 200241 ChinaShanghai Frontiers Science Center of Genome Editing and Cell Therapy Biomedical Synthetic Biology Research Center Shanghai Key Laboratory of Regulatory Biology Institute of Biomedical Sciences and School of Life Sciences East China Normal University Dongchuan Road 500 Shanghai 200241 ChinaShanghai Frontiers Science Center of Genome Editing and Cell Therapy Biomedical Synthetic Biology Research Center Shanghai Key Laboratory of Regulatory Biology Institute of Biomedical Sciences and School of Life Sciences East China Normal University Dongchuan Road 500 Shanghai 200241 ChinaShanghai Frontiers Science Center of Genome Editing and Cell Therapy Biomedical Synthetic Biology Research Center Shanghai Key Laboratory of Regulatory Biology Institute of Biomedical Sciences and School of Life Sciences East China Normal University Dongchuan Road 500 Shanghai 200241 ChinaDepartment of Animal Sciences, College of Agriculture and Natural Resources Michigan State University East Lansing MI 48824 USAShanghai Frontiers Science Center of Genome Editing and Cell Therapy Biomedical Synthetic Biology Research Center Shanghai Key Laboratory of Regulatory Biology Institute of Biomedical Sciences and School of Life Sciences East China Normal University Dongchuan Road 500 Shanghai 200241 ChinaAbstract Pluripotent stem cells (PSCs) hold great promise for cell‐based therapies, disease modeling, and drug discovery. Classic somatic cell reprogramming to generate induced pluripotent stem cells (iPSCs) is often achieved based on overexpression of transcription factors (TFs). However, this process is limited by side effect of overexpressed TFs and unpredicted targeting of TFs. Pinpoint control over endogenous TFs expression can provide the ability to reprogram cell fate and tissue function. Here, a light‐inducible cell reprogramming (LIRE) system is developed based on a photoreceptor protein cryptochrome system and clustered regularly interspaced short palindromic repeats/nuclease‐deficient CRISPR‐associated protein 9 for induced PSCs reprogramming. This system enables remote, non‐invasive optogenetical regulation of endogenous Sox2 and Oct4 loci to reprogram mouse embryonic fibroblasts into iPSCs (iPSCLIRE) under light‐emitting diode‐based illumination. iPSCLIRE cells can be efficiently differentiated into different cells by upregulating a corresponding TF. iPSCLIRE cells are used for blastocyst injection and optogenetic chimeric mice are successfully generated, which enables non‐invasive control of user‐defined endogenous genes in vivo, providing a valuable tool for facile and traceless controlled gene expression studies and genetic screens in mice. This LIRE system offers a remote, traceless, and non‐invasive approach for cellular reprogramming and modeling of complex human diseases in basic biological research and regenerative medicine applications.https://doi.org/10.1002/advs.202202858cell reprogrammingchimeric miceendogenous transcription factorsoptogeneticsregenerative medicines
spellingShingle Meiyan Wang
Yuanxiao Liu
Ziwei Wang
Longliang Qiao
Xiaoding Ma
Lingfeng Hu
Deqiang Kong
Yuan Wang
Haifeng Ye
An Optogenetic‐Controlled Cell Reprogramming System for Driving Cell Fate and Light‐Responsive Chimeric Mice
Advanced Science
cell reprogramming
chimeric mice
endogenous transcription factors
optogenetics
regenerative medicines
title An Optogenetic‐Controlled Cell Reprogramming System for Driving Cell Fate and Light‐Responsive Chimeric Mice
title_full An Optogenetic‐Controlled Cell Reprogramming System for Driving Cell Fate and Light‐Responsive Chimeric Mice
title_fullStr An Optogenetic‐Controlled Cell Reprogramming System for Driving Cell Fate and Light‐Responsive Chimeric Mice
title_full_unstemmed An Optogenetic‐Controlled Cell Reprogramming System for Driving Cell Fate and Light‐Responsive Chimeric Mice
title_short An Optogenetic‐Controlled Cell Reprogramming System for Driving Cell Fate and Light‐Responsive Chimeric Mice
title_sort optogenetic controlled cell reprogramming system for driving cell fate and light responsive chimeric mice
topic cell reprogramming
chimeric mice
endogenous transcription factors
optogenetics
regenerative medicines
url https://doi.org/10.1002/advs.202202858
work_keys_str_mv AT meiyanwang anoptogeneticcontrolledcellreprogrammingsystemfordrivingcellfateandlightresponsivechimericmice
AT yuanxiaoliu anoptogeneticcontrolledcellreprogrammingsystemfordrivingcellfateandlightresponsivechimericmice
AT ziweiwang anoptogeneticcontrolledcellreprogrammingsystemfordrivingcellfateandlightresponsivechimericmice
AT longliangqiao anoptogeneticcontrolledcellreprogrammingsystemfordrivingcellfateandlightresponsivechimericmice
AT xiaodingma anoptogeneticcontrolledcellreprogrammingsystemfordrivingcellfateandlightresponsivechimericmice
AT lingfenghu anoptogeneticcontrolledcellreprogrammingsystemfordrivingcellfateandlightresponsivechimericmice
AT deqiangkong anoptogeneticcontrolledcellreprogrammingsystemfordrivingcellfateandlightresponsivechimericmice
AT yuanwang anoptogeneticcontrolledcellreprogrammingsystemfordrivingcellfateandlightresponsivechimericmice
AT haifengye anoptogeneticcontrolledcellreprogrammingsystemfordrivingcellfateandlightresponsivechimericmice
AT meiyanwang optogeneticcontrolledcellreprogrammingsystemfordrivingcellfateandlightresponsivechimericmice
AT yuanxiaoliu optogeneticcontrolledcellreprogrammingsystemfordrivingcellfateandlightresponsivechimericmice
AT ziweiwang optogeneticcontrolledcellreprogrammingsystemfordrivingcellfateandlightresponsivechimericmice
AT longliangqiao optogeneticcontrolledcellreprogrammingsystemfordrivingcellfateandlightresponsivechimericmice
AT xiaodingma optogeneticcontrolledcellreprogrammingsystemfordrivingcellfateandlightresponsivechimericmice
AT lingfenghu optogeneticcontrolledcellreprogrammingsystemfordrivingcellfateandlightresponsivechimericmice
AT deqiangkong optogeneticcontrolledcellreprogrammingsystemfordrivingcellfateandlightresponsivechimericmice
AT yuanwang optogeneticcontrolledcellreprogrammingsystemfordrivingcellfateandlightresponsivechimericmice
AT haifengye optogeneticcontrolledcellreprogrammingsystemfordrivingcellfateandlightresponsivechimericmice